Antibacterial use in the age of SARS-CoV-2.

Kathleen E AngellJames V LawlerAngela L HewlettMark E RuppScott J Bergman Trevor C Van SchooneveldM Jana BroadhurstDavid M Brett-Major

Published in: JAC-antimicrobial resistance (2021)

Antibacterial therapy prescription differs by COVID-19 disease status, and procalcitonin results are most highly associated with antibacterial use across strata.

Keyphrases

sars cov
silver nanoparticles
coronavirus disease
respiratory syndrome coronavirus
essential oil
anti inflammatory
wound healing
stem cells
bone marrow
smoking cessation